Maj Invest Holding A S Makes New Investment in HCA Healthcare, Inc. (NYSE:HCA)

Maj Invest Holding A S purchased a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) in the first quarter, according to its most recent filing with the SEC. The firm purchased 317,826 shares of the company's stock, valued at approximately $109,823,000. HCA Healthcare accounts for about 4.0% of Maj Invest Holding A S's portfolio, making the stock its 16th largest position. Maj Invest Holding A S owned about 0.13% of HCA Healthcare at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Congress Wealth Management LLC DE raised its holdings in shares of HCA Healthcare by 3.4% during the fourth quarter. Congress Wealth Management LLC DE now owns 1,039 shares of the company's stock valued at $312,000 after acquiring an additional 34 shares during the period. Perigon Wealth Management LLC increased its stake in shares of HCA Healthcare by 2.3% during the 1st quarter. Perigon Wealth Management LLC now owns 1,797 shares of the company's stock worth $621,000 after purchasing an additional 40 shares during the last quarter. Whittier Trust Co. boosted its holdings in shares of HCA Healthcare by 3.6% during the 4th quarter. Whittier Trust Co. now owns 1,195 shares of the company's stock worth $359,000 after buying an additional 41 shares during the period. Barden Capital Management Inc. boosted its holdings in shares of HCA Healthcare by 1.4% during the 1st quarter. Barden Capital Management Inc. now owns 2,921 shares of the company's stock worth $1,009,000 after buying an additional 41 shares during the period. Finally, Coldstream Capital Management Inc. boosted its holdings in HCA Healthcare by 1.3% in the 4th quarter. Coldstream Capital Management Inc. now owns 3,471 shares of the company's stock valued at $1,042,000 after purchasing an additional 44 shares during the period. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of equities research analysts recently issued reports on the stock. Baird R W cut shares of HCA Healthcare from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, April 15th. Royal Bank Of Canada reaffirmed an "outperform" rating and issued a $404.00 price objective (up from $376.00) on shares of HCA Healthcare in a research note on Monday, June 23rd. Stephens raised shares of HCA Healthcare to a "strong-buy" rating in a research report on Monday, June 2nd. Barclays set a $416.00 price objective on shares of HCA Healthcare and gave the company an "overweight" rating in a research report on Monday, June 2nd. Finally, Morgan Stanley set a $410.00 price target on shares of HCA Healthcare and gave the company an "equal weight" rating in a research note on Monday, June 9th. Seven equities research analysts have rated the stock with a hold rating, eleven have assigned a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $395.71.

Insider Activity

In other HCA Healthcare news, COO Jon M. Foster sold 15,698 shares of HCA Healthcare stock in a transaction that occurred on Tuesday, May 13th. The shares were sold at an average price of $369.32, for a total transaction of $5,797,585.36. Following the transaction, the chief operating officer owned 12,646 shares of the company's stock, valued at $4,670,420.72. The trade was a 55.38% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 1.30% of the stock is currently owned by insiders.

HCA Healthcare Price Performance

NYSE:HCA traded up $0.67 during mid-day trading on Wednesday, hitting $378.27. 972,606 shares of the stock traded hands, compared to its average volume of 1,460,972. The business's 50-day moving average price is $373.21 and its 200 day moving average price is $340.45. The company has a market cap of $91.00 billion, a PE ratio of 16.82, a price-to-earnings-growth ratio of 1.31 and a beta of 1.47. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $417.14. The company has a quick ratio of 1.06, a current ratio of 1.19 and a debt-to-equity ratio of 69.07.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings data on Friday, April 25th. The company reported $6.45 earnings per share for the quarter, topping analysts' consensus estimates of $5.75 by $0.70. HCA Healthcare had a net margin of 8.07% and a return on equity of 1,063.91%. The firm had revenue of $18.32 billion during the quarter, compared to analyst estimates of $18.26 billion. During the same period in the previous year, the business posted $5.36 EPS. The business's quarterly revenue was up 5.7% on a year-over-year basis. On average, analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, June 30th. Stockholders of record on Monday, June 16th were issued a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.76%. The ex-dividend date of this dividend was Monday, June 16th. HCA Healthcare's payout ratio is presently 12.81%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.